Minerva Neurosciences Inc (NERV)

NASDAQ HEALTHCARE
$6.47 +1.25% RSI 50 Neutral Add Alert

Moving Averages

SMA 200
$3.82
Price above

Company Profile

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of candidate products for the treatment of diseases of the central nervous system. The company is headquartered in Waltham, Massachusetts.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$238.44M
P/E Ratio
None
EPS
$-34.67
Beta
-0.207
Dividend Yield
0.00%
52-Week High
$8.8
52-Week Low
$1.3

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 57.0
VRTX
Vertex Pharmaceuticals Inc
RSI 41.0
CRSP
CRISPR Therapeutics AG
RSI 50.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 50.0
MRNA
Moderna Inc
RSI 36.0
VKTX
Viking Therapeutics Inc
RSI 38.0

Data last updated: April 11, 2026 at 1:12 PM EDT

Track NERV for free

Get e-mail RSI alerts when Minerva Neurosciences Inc enters oversold or overbought territory. Free forever.

Add Alert